Ketogenic Diet for Stage IV Cancer
Also known as: Keto diet, LCHF, Metabolic therapy
The ketogenic diet exploits the Warburg effect — cancer cells' glucose dependency — by restricting carbohydrates and shifting host metabolism to ketosis.
Mechanism of Action
Carbohydrate restriction reduces blood glucose and insulin levels. Beta-hydroxybutyrate (BHB) provides alternative fuel for normal cells but not for most cancer cells (which lack the enzymes for ketone utilization). Additionally, BHB inhibits HDAC enzymes, reduces mTOR signaling, enhances oxidative stress in cancer cells, and suppresses inflammation.
General mechanism: High-fat, very-low-carbohydrate diet inducing ketosis. BHB serves as alternative fuel, HDAC inhibitor, AMPK activator, anti-inflammatory agent.
Current Evidence
Phase I/II trials for glioblastoma (as adjunct to standard treatment) show feasibility and safety. Preclinical evidence strong for metabolic targeting. Press-pulse metabolic therapy (ketogenic diet + glycolysis inhibitors) is theoretical but promising. Patient adherence is the primary challenge.
Clinical Status: Phase I/II for glioblastoma and other cancers. Feasibility demonstrated. Not yet standard of care.
Safety Profile
Generally safe with medical supervision. Kidney stone risk, lipid profile changes, nutritional deficiencies without supplementation. Contraindicated in fatty acid oxidation disorders.
Key Research Questions
- Can ketogenic diet sensitize tumors to checkpoint inhibitors or radiation?
- What is the optimal ketone level for anti-cancer effect?
- Does combination with DCA or 2-DG provide synergistic metabolic targeting?
Frequently Asked Questions
Does the ketogenic diet help with cancer?
The ketogenic diet exploits the Warburg effect — cancer cells' dependence on glucose. Clinical trials in glioblastoma show safety and metabolic benefits as adjunctive therapy. It may enhance chemotherapy and radiation effectiveness. It's studied as complementary, not replacement, therapy.
Ketogenic diet for Alzheimer's prevention
Alzheimer's involves impaired brain glucose metabolism (sometimes called 'type 3 diabetes'). Ketones provide an alternative brain fuel. The modified Mediterranean-ketogenic diet (MMKD) trial showed improved CSF Alzheimer's biomarkers. Most promising for MCI and early-stage prevention.